Concepedia

Publication | Open Access

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma

17

Citations

39

References

2021

Year

Abstract

Our results suggest that axitinib is a compelling candidate for MB treatment.

References

YearCitations

Page 1